Discover KADCYLA® (ado-trastuzumab emtansine), a treatment for HER2-positive metastatic breast cancer.
Indication Statement
Who is KADCYLA® for?
KADCYLA is approved to treat HER2-positive breast cancer that has spread to other parts of the body (metast